, , p.41
, , p.41
, , p.41
, , p.42
, , p.42
, , p.43
, , p.44
, , p.44
, , p.45
, , p.45
, , p.45
, , p.47
, , p.49
, , p.49
, , p.49
, , p.50
, , p.50
, , p.50
, , p.51
, , p.52
, , p.52
, , p.53
, , p.53
, , p.53
, , p.55
, , p.55
, , p.56
, , p.58
, , p.59
, , p.60
, , p.60
, , p.61
, , p.62
, , p.64
, , p.65
, , p.65
, , p.66
, , p.67
, , p.69
, , p.74
, , p.75
CCAFU french national guidelines 2016-2018 on prostate cancer]. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol, pp.95-143, 2016. ,
Epidemiologie nationale du cancer de la prostate-données essentielles Disponibles sur https://lesdonneesecancerfr/les-fiches-de-synthese/1-types-cancer/10- cancer-prostate/19-epidemiologie-cancer-prostate-france-metropolitaineessentielleshtlm- ind4, 2012. ,
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent???Update 2013, European Urology, vol.65, issue.1, pp.124-161, 2014. ,
DOI : 10.1016/j.eururo.2013.09.046
Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons, BJU International, vol.9, issue.2, pp.162-73, 2002. ,
DOI : 10.1002/sim.4780090506
, Numéro thématique ? Chlordécone aux Antilles : bilan actualisé des risques sanitaires http://www.invs.sante, BEH, pp.3-4, 2011.
The prostate gland: a crossroad between the urinary and the seminal tracts], Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. 2012, vol.22, issue.1, pp.2-6 ,
The zonal anatomy of the prostate. The Prostate, pp.35-49, 1981. ,
Normal Histology of the Prostate, The American Journal of Surgical Pathology, vol.12, issue.8, pp.619-652, 1988. ,
DOI : 10.1097/00000478-198808000-00003
, Cancer de la prostate (Guide affection de longue durée) HAS, HAS, 2012.
Contemporary Gleason Grading of Prostatic Carcinoma, International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma, 2014. ,
DOI : 10.1097/PAS.0000000000000820
PREOPERATIVE MODEL FOR PREDICTING PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY USING PERCENT OF BIOPSY TISSUE WITH CANCER, BIOPSY GLEASON GRADE AND SERUM PROSTATE SPECIFIC ANTIGEN, The Journal of Urology, vol.171, issue.6, pp.2215-2235, 2004. ,
DOI : 10.1097/01.ju.0000124463.13319.0a
, The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma]. Pathol. 2016 Feb, pp.17-26
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up, JNCI Journal of the National Cancer Institute, vol.341, issue.sep14_1, pp.125-157, 2012. ,
DOI : 10.1136/bmj.c4543
Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical Prostatectomy, European Urology, vol.52, issue.1, pp.29-37, 2007. ,
DOI : 10.1016/j.eururo.2007.04.020
Benefit of intensity modulated and image-guided radiotherapy in prostate cancer], Cancer Radiother J Soc Francaise Radiother Oncol, vol.14, pp.6-7479, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00909914
Recommandations en Onco-Urologie 2010 : Cancer de la prostate, Progr??s en Urologie, vol.20, issue.4, pp.217-251, 2010. ,
DOI : 10.1016/S1166-7087(10)70042-7
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study, The Lancet Oncology, vol.13, issue.10, pp.983-92, 2012. ,
DOI : 10.1016/S1470-2045(12)70379-0
Prostate Cancer: Role of Pretreatment Multiparametric 3-T MRI in Predicting Biochemical Recurrence After Radical Prostatectomy, American Journal of Roentgenology, vol.202, issue.5, pp.459-465, 2014. ,
DOI : 10.2214/AJR.13.11381
Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer, Clinical Nuclear Medicine, vol.38, issue.5, pp.305-319, 2013. ,
DOI : 10.1097/RLU.0b013e3182867f3c
The role of choline in prostate cancer, Clinical Biochemistry, vol.45, issue.18, pp.1548-53, 2012. ,
DOI : 10.1016/j.clinbiochem.2012.08.012
PET imaging of prostate cancer using carbon-11-choline, J Nucl Med Off Publ Soc Nucl Med, vol.39, issue.6, pp.990-995, 1998. ,
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer, Cancer Res, vol.61, issue.1, pp.110-117, 2001. ,
Quantification of 18F-Fluorocholine Kinetics in Patients with Prostate Cancer, Journal of Nuclear Medicine, vol.56, issue.3, pp.365-71 ,
DOI : 10.2967/jnumed.114.148007
URL : http://jnm.snmjournals.org/content/56/3/365.full.pdf
Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT, Nuclear Medicine Communications, vol.32, issue.12, pp.1143-1150, 2011. ,
DOI : 10.1097/MNM.0b013e32834b76fa
Dual-Phase PET-CT to Differentiate [18F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer, PLoS ONE, vol.154, issue.2, p.48430, 2012. ,
DOI : 10.1371/journal.pone.0048430.t003
URL : https://doi.org/10.1371/journal.pone.0048430
Pharmacokinetics and radiation dosimetry of 18F-fluorocholine, J Nucl Med Off Publ Soc Nucl Med, 2002. ,
Performance characteristics obtained for a new 3-dimensional lutetium oxyorthosilicate-based wholebody PET/CT scanner with the National Electrical Manufacturers Association NU 2-2001 standard, J Nucl Med Off Publ Soc Nucl Med, vol.46, issue.12, pp.2083-91, 2005. ,
Exact and approximate rebinning algorithms for 3-D PET data, IEEE Transactions on Medical Imaging, vol.16, issue.2, 1997. ,
DOI : 10.1109/42.563660
Prostate Cancer: Role of SPECT and PET in Imaging Bone Metastases, Seminars in Nuclear Medicine, vol.39, issue.6, pp.396-407, 2009. ,
DOI : 10.1053/j.semnuclmed.2009.05.003
New acquisition protocol of 18F-choline PET/CT in prostate cancer patients: review of the literature about methodology and proposal of standardization, BioMed Res Int, vol.2014, p.215650, 2014. ,
TEP/TDM ?? la 18-fluorocholine dans le cancer de prostate??: quel protocole d???acquisition???, M??decine Nucl??aire, vol.40, issue.4, pp.307-321, 2016. ,
DOI : 10.1016/j.mednuc.2016.03.140
The Role of 11C-Choline and 18F-Fluorocholine Positron Emission Tomography (PET) and PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis, European Urology, vol.64, issue.1, pp.106-123 ,
DOI : 10.1016/j.eururo.2013.04.019
Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging, Journal of Nuclear Medicine, vol.57, issue.Supplement_3, pp.38-42, 2016. ,
DOI : 10.2967/jnumed.115.169748
URL : http://jnm.snmjournals.org/content/57/Supplement_3/38S.full.pdf
Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer. The Prostate, Feb, vol.1575, issue.3, pp.323-354, 2015. ,
Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis, European Urology, vol.63, issue.6, pp.1040-1048 ,
DOI : 10.1016/j.eururo.2012.09.039
The Role of 11C-Choline and 18F-Fluorocholine Positron Emission Tomography (PET) and PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis, European Urology, vol.64, issue.1, pp.106-123 ,
DOI : 10.1016/j.eururo.2013.04.019
Impact of 18F-Choline PET/CT in Prostate Cancer Patients with Biochemical Recurrence: Influence of Androgen Deprivation Therapy and Correlation with PSA Kinetics, Journal of Nuclear Medicine, vol.54, issue.6, pp.833-873, 2013. ,
DOI : 10.2967/jnumed.112.110148
Role of 18F-Choline PET/CT in Biochemically Relapsed Prostate Cancer After Radical Prostatectomy, Clinical Nuclear Medicine, vol.38, issue.1, pp.26-32, 2013. ,
DOI : 10.1097/RLU.0b013e318266cc38
18F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging, European Journal of Nuclear Medicine and Molecular Imaging, vol.168, issue.Suppl 2, pp.14-22, 2011. ,
DOI : 10.1148/radiology.199.3.8638000
??l??vation du PSA apr??s irradiation prostatique??: rebond ou r??cidive biologique???, Progr??s en Urologie, vol.18, issue.9, 2008. ,
DOI : 10.1016/j.purol.2008.06.001
Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging, Annals of Nuclear Medicine, vol.32, issue.Suppl 1, 2012. ,
DOI : 10.1097/MNM.0b013e32834b76fa
Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy, European Journal of Nuclear Medicine and Molecular Imaging, vol.35, issue.Suppl 1, pp.271-82, 2012. ,
DOI : 10.1007/s00259-008-0716-2
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer, European Urology, vol.59, issue.1, pp.51-60, 2011. ,
DOI : 10.1016/j.eururo.2010.09.004
Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.35, issue.2, pp.41-47 ,
DOI : 10.1007/s00259-007-0552-9
Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.47, issue.6, pp.936-979 ,
DOI : 10.1016/j.eururo.2011.07.060
URL : http://www.zora.uzh.ch/id/eprint/62296/4/PaperArztdaten_Soyka_EJNM_revised_10.01.2012-1.pdf